WKN DE: A407YS / ISIN: US8162123025

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Cartesian Therapeutics Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Cartesian Therapeutics Inc Registered Shs

Weitere Meldungen

02:47		Nebius Just Raised $5 Billion in Convertible Notes Against a $1.4 Billion Revenue Base. Are We In a Bubble?
02:25		Red Cat CEO Jeffrey Thompson Sells 150,000 Shares for $1.6 Million as the Stock Soars 24%
02:13		Cisco & Cerebras Orders Up, Stocks Down
02:05		$5,000 in Bloom Energy at Its COVID-Era Low Would Be Worth This Much Now
01:37		Is It Too Late to Buy Sandisk After Its 568% Run?
01:05		GE Vernova's Backlog Is Bigger Than Some Countries' GDP. Here's What's Actually Inside the $176 Billion.
00:56		Volkswagen vor Schicksalswoche: VW-Chef Blume verlangt Schulterschluss der Mitarbeiter
00:41		The 30-Year Treasury Now Out-Yields Dividend Stocks by 2.2 Points. History Says What Followed the Last Time.
00:00		Apple Announced Its Largest-Ever Stock Buyback Under Tim Cook's Leadership. Here's Why the Size of the Repurchase Program Matters for Shareholders.
22.08.26		Institutional Investors Are Buying Hyperliquid Strategies. Should You?
22.08.26		Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700
22.08.26		This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.
22.08.26		Trump’s Top Trade Representative Details Offer That Canada Rejected
22.08.26		Reddit vs. Rigetti Computing: Which High-Growth Stock Is a Better Buy in 2026, the Social Media Giant or Rising Quantum Computing Company?
22.08.26		Strive Director Pierre Rochard Buys 15,900 Shares After 86% Decline. Is a Rebound Coming?
22.08.26		American Assets Trust Executive Chairman Rady Buys $1. Million Shares. Is This a Sign for Investors to Buy?
22.08.26		Ross Stores Grew Comparable Sales 10%. TJX Grew 4%. Only One Stock Went Up.
22.08.26		If You're 60 Years Old and Have This 401(k) Balance, You're Ahead of Your Peers
22.08.26		Alpha Metallurgical Resources Director Courtis Buys $2.9 Million Shares. What Does This Mean for Investors?
22.08.26		Billionaire Stanley Druckenmiller Just Sold Some Sandisk Stock and Bought These 3 Unstoppable Artificial Intelligence (AI) Stocks
22.08.26		Apple vs. Meta Platforms: Which "Magnificent Seven" Giant Has the Stronger Artificial Intelligence (AI) Growth Engine?
22.08.26		Does Greg Abel Know Something Wall Street Doesn't? New Berkshire Hathaway CEO Doubles Down On a Legacy Department Store Stock With a 3.3% Dividend Yield
22.08.26		Steve Jobs Once Taught Andy Warhol How to Use a Macintosh Mouse—The Pop Art Icon Was ‘Spellbound’
22.08.26		Amazon's Custom Chip Business Crossed a $25 Billion Run Rate: Time to Load Up on Shares?
22.08.26		I've Held Microsoft for 10 Years. Here's Why I'm Not Selling a Single Share.
22.08.26		Nvidia Stock Looks Like It's Slowing Down. The Market May Be Wrong.
22.08.26		CoreWeave CEO Michael Intrator Sold Over 13,000 Shares for $1.2 Million. What Does This Mean for Investors?
22.08.26		Warren Buffett's Hand-Picked Successor, Greg Abel, Has 72% of Berkshire Hathaway's Portfolio Invested in Just 5 Stocks. Here's My Top Pick for August.
22.08.26		Which Consumer Staples ETF Is a Better Buy: Invesco's RSPS or SPDR's XLP?
22.08.26		Bitcoin Price Prediction as Monthly ETF Inflows Hit a Key Milestone
22.08.26		Canada to hit back with retaliatory tariffs after US trade talks fail
22.08.26		Elon Musk Doesn't 'Really Buy Stocks' — but He Named 3 Things He Looks For in a Company
22.08.26		Executive Parts Ways With 4,000 Shares of Regional Bank Stock, Following 11% Rally
22.08.26		1 Quantum Computing Stock That Looks Like a Screaming Buy Right Now
22.08.26		U.S. Economy Could Feel the Sting From Trade War With Canada
22.08.26		Mark Carney says Canada is now ‘at war’ with US over trade
22.08.26		Treasury Yields Have Surged. Is It Finally Time to Buy Bond ETFs?
22.08.26		Paramount and California to Hold Preliminary Talks on Warner Bros. Deal
22.08.26		Netflix Co-Founder Reed Hastings Got Thrown Out of Homes as a Door-to-Door Vacuum Salesperson: This Is What the Job Taught Him
22.08.26		This S&P 500 Stock Pays a 2.67% Dividend Yield and Has Increased Its Payout in 17 Straight Years. Here's Why None of This Matters to Investors as Much as the Federal Reserve and Kevin Warsh.
22.08.26		TLT ETF Inflows Steady as 30-Year Treasury Yield Rebounds Amid Rising Risks
22.08.26		CVS Health Stock Is Beating the Market in 2026. Here's Why Wall Street Thinks It Can Soar Another 22%.
22.08.26		JPMorgan Chase CEO Jamie Dimon Dropped a 9-Word Warning: "Margin Debt Is the Highest It Has Ever Been." Should Investors Be Worried?
22.08.26		LinkedIn-Nutzer melden etliche Beiträge als KI-Slop
22.08.26		Billionaire Stephen Mandel Just Loaded Up on This Incredible Artificial Intelligence (AI) Stock Up Nearly 200% in 2026
22.08.26		The S&P 500 Is Near an All-Time High. Here's What History Says Investors Should Do.
22.08.26		Can Bloom Energy Keep Beating the Market?
22.08.26		Pinterest Insider Dumps Nearly 94,000 Shares, After Stock Drops by 33% Over Last Year
22.08.26		Samsung zeigt 300-Hertz-OLED für Notebooks
22.08.26		Forget Rate Hikes. These 3 Vanguard ETFs Could Be Better Positioned for What Comes Next.

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Hightide Therapeutics Microfinance company "Zaymer" Joint Stock Company Registered Shs Charles Schwab Helix Exploration Pinterest

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	23.08.2026 03:47
Kaufwert:	EUR
	Hinzufügen Speichern

Cartesian Therapeutics Aktie

WKN DE: A407YS / ISIN: US8162123025

Cartesian Therapeutics Times and Sales (STU)

Times and Sales

Analysen zu Cartesian Therapeutics Inc Registered Shs

Weitere Meldungen